Association of Genetic Variants in NUDT15 with Thiopurine-Induced Myelosuppression in Patients with Inflammatory Bowel Disease

Gareth J. Walker, James W. Harrison, Graham A. Heap, Michiel D. Voskuil, Vibeke Andersen, Carl A. Anderson, Ashwin N. Ananthakrishnan, Jeffrey C. Barrett, Laurent Beaugerie, Claire M. Bewshea, Andy T. Cole, Fraser R. Cummings, Mark J. Daly, Pierre Ellul, Richard N. Fedorak, Eleonora A.M. Festen, Timothy H. Florin, Daniel R. Gaya, Jonas Halfvarson, Ailsa L. HartNeel M. Heerasing, Peter Hendy, Peter M. Irving, Samuel E. Jones, Jukka Koskela, James O. Lindsay, John C. Mansfield, Dermot McGovern, Miles Parkes, Richard C.G. Pollok, Subramaniam Ramakrishnan, David S. Rampton, Manuel A. Rivas, Richard K. Russell, Michael Schultz, Shaji Sebastian, Philippe Seksik, Abhey Singh, Kenji So, Harry Sokol, Kavitha Subramaniam, Anthony Todd, Vito Annese, Rinse K. Weersma, Ramnik Xavier, Rebecca Ward, Michael N. Weedon, James R. Goodhand, Nicholas A. Kennedy, Tariq Ahmad, IBD Pharmacogenetics Study Group, Jane Andrews, Peter Bampton, David Campbell, Matt Johnson, Malcolm Smith, Christine R. Stevens, Matthew R. NelsonShow 38 moreShow less